Sàn giao dịch: Frankfurt Khu vực: Chăm sóc sức khỏe Ngành: Công nghệ sinh học Thị trường chứng khoán - Báo giá & giá
Danh sách tất cả các chứng khoán và vốn chủ sở hữu kèm giá, vốn hoá thị trường, PE và EPS
Tất cả các quốc gia
- {{country.name}}
- Tất cả các quốc gia
- Đức (648)
Frankfurt (648)
- {{item.name}}
- Tất cả các sàn giao dịch
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (285)
- NasdaqGM (149)
- NasdaqGS (226)
- NSE (10)
- NYSE (10)
- NYSE American (19)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (112)
- OTC Markets OTCPK (125)
- OTC Markets OTCQB (38)
- OTC Markets OTCQX (8)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Chăm sóc sức khỏe (648)
- {{item.name}}
- Tất cả các khối
- Chăm sóc sức khỏe (648)
Công nghệ sinh học (648)
- {{item.name}}
- Tất cả các ngành
- Công nghệ sinh học (648)
- Nhà sản xuất thuốc - Chung (45)
- Nhà sản xuất thuốc - Biệt dược & Thuốc gốc (277)
- Gói y tế (9)
- Cơ sơ chăm sóc y tế (93)
- Nhà bán lẻ thuốc (21)
- Dịch vụ thông tin sức khỏe (81)
- Thiết bị y tế (202)
- Thiết bị & nguồn cung y tế (106)
- Chẩn đoán & nghiên cứu (102)
- Phân phối y tế (22)
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS |
|---|
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Sino Biopharmaceutical Limited SMZ1.F | $0.4899 0.54 USD |
-3.2
|
$8.96B 9.79B USD | $4K 4.37K USD | $0.4899 0.54 USD | $0.4899 0.54 USD | $8.96B 9.79B USD | 49.25 | $0.01 0.01 USD | |
| BB Biotech AG Ord BBZA.F | $32.25 35.25 USD |
-1.68
|
$1.79B 1.96B USD | $2.77K 3.02K USD | $32.25 35.25 USD | $32.9 35.96 USD | $1.79B 1.96B USD | 13.21 | $2.44 2.67 USD | |
| CureVac N.V. 5CV.F | $3.87 4.23 USD |
-2.03
|
$871.37M 952.52M USD | $16.34K 17.86K USD | $3.75 4.1 USD | $3.99 4.36 USD | $871.37M 952.52M USD | 4.83 | $0.8 0.87 USD | |
| CStone Pharmaceuticals PH4.F | $0.4299 0.47 USD |
-0.92
|
$602.21M 658.29M USD | $39.51K 43.19K USD | $0.4299 0.47 USD | $0.4299 0.47 USD | $602.21M 658.29M USD | 0 | -$0.01 -0.01 USD | |
| Valneva SE AYJ.F | $2.76 3.01 USD |
+0.44
|
$472.79M 516.83M USD | $6.51K 7.12K USD | $2.75 3.01 USD | $2.79 3.05 USD | $472.79M 516.83M USD | 0 | -$0.56 -0.6 USD | |
| Ocugen, Inc. 2H51.F | $0.8499 0.93 USD |
+10.86
|
$252.33M 275.83M USD | $18.05K 19.73K USD | $0.75 0.82 USD | $0.8699 0.95 USD | $252.33M 275.83M USD | 0 | -$0.18 -0.1 USD | |
| Abliva AB (publ) NTP.F | $0.04 0.04 USD |
0
|
$64.47M 70.47M USD | $4K 4.37K USD | $0.02999 0.03 USD | $0.04 0.04 USD | $64.47M 70.47M USD | 0 | -$0.01 -0.01 USD | |
| Alterity Therapeutics Limited PBN.F | $0.005 0.0054 USD |
0
|
$60.57M 66.21M USD | $480K 524.7K USD | $0.005 0.0054 USD | $0.005 0.0054 USD | $60.57M 66.21M USD | 0 | $0 0 USD | |
| InflaRx N.V. IF0.F | $0.7399 0.81 USD |
-5.01
|
$50.13M 54.8M USD | $10.6K 11.59K USD | $0.7299 0.8 USD | $0.7399 0.81 USD | $50.13M 54.8M USD | 0 | -$0.74 -0.8 USD | |
| Defence Therapeutics Inc. DTC.F | $0.54 0.59 USD |
+4.23
|
$29.66M 32.42M USD | $2.2K 2.4K USD | $0.4199 0.46 USD | $0.54 0.59 USD | $29.66M 32.42M USD | 0 | -$0.05 -0.05 USD | |
| Active Biotech AB (publ) BTPC.F | $0.02 0.02 USD |
-15.87
|
$26.08M 28.51M USD | $41.46K 45.32K USD | $0.02 0.02 USD | $0.02 0.02 USD | $26.08M 28.51M USD | 0 | -$0.01 -0.01 USD | |
| Glow Lifetech Corp. 9DO.F | $0.02999 0.03 USD |
0
|
$5.82M 6.36M USD | $5K 5.47K USD | $0.02999 0.03 USD | $0.02999 0.03 USD | $5.82M 6.36M USD | 0 | -$0.02 -0.02 USD | |
| BioVaxys Technology Corp. 5LB.F | $0.01 0.01 USD |
-52
|
$3.58M 3.92M USD | $23K 25.14K USD | $0.01 0.01 USD | $0.01 0.01 USD | $3.58M 3.92M USD | 0 | -$0.01 -0.01 USD | |
| Medigene AG MDG1.F | $0.08999 0.1 USD |
+0.69
|
$1.97M 2.15M USD | $3.13K 3.42K USD | $0.08 0.09 USD | $0.08999 0.1 USD | $1.97M 2.15M USD | 0 | -$1.21 -1.3 USD | |
| BioSenic S.A. BT1.F | $0.001399 0.0015 USD |
-17.65
|
$1.02M 1.12M USD | $23K 25.14K USD | $0.001399 0.0015 USD | $0.0015 0.0016 USD | $1.02M 1.12M USD | 0 | -$0.04 -0.04 USD | |
| Novo Nordisk A/S NOVA.F | $63.1 68.98 USD |
+0.16
|
$284.44B 310.93B USD | $529 578.27 USD | $63 68.87 USD | $64.4 70.4 USD | $284.44B 310.93B USD | 20.03 | $3.15 3.44 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $390.55 426.92 USD |
-0.04
|
$100.54B 109.91B USD | $5 5.47 USD | $389.8 426.1 USD | $390.55 426.92 USD | $100.54B 109.91B USD | 0 | -$3.36 -3.6 USD | |
| CSL Limited CSJ.F | $137.14 149.91 USD |
-1.21
|
$66.89B 73.12B USD | $50 54.66 USD | $136.78 149.52 USD | $137.14 149.91 USD | $66.89B 73.12B USD | 28.63 | $4.79 5.24 USD | |
| CSL Limited CSJA.F | $68 74.33 USD |
-1.45
|
$66.73B 72.95B USD | $5 5.47 USD | $68 74.33 USD | $68 74.33 USD | $66.73B 72.95B USD | 28.45 | $2.39 2.61 USD | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $264.9 289.57 USD |
+0.08
|
$35.15B 38.42B USD | $37 40.45 USD | $264.9 289.57 USD | $264.9 289.57 USD | $35.15B 38.42B USD | 0 | -$1.83 -2.0004 USD | |
| argenx SE 1AEA.F | $496 542.2 USD |
-0.8
|
$30.87B 33.74B USD | $9 9.84 USD | $496 542.2 USD | $496 542.2 USD | $30.87B 33.74B USD | 34.44 | $14.4 15.74 USD | |
| argenx SE 1AE.F | $502 548.75 USD |
-1.1
|
$30.77B 33.64B USD | $10 10.93 USD | $502 548.75 USD | $502 548.75 USD | $30.77B 33.64B USD | 34.81 | $14.42 15.76 USD | |
| UCB SA UNC.F | $161.05 176.05 USD |
-0.37
|
$30.61B 33.46B USD | $15 16.4 USD | $161.05 176.05 USD | $161.05 176.05 USD | $30.61B 33.46B USD | 29.38 | $5.48 5.99 USD | |
| UCB SA UNC0.F | $79.5 86.9 USD |
+1.27
|
$30.59B 33.44B USD | $50 54.66 USD | $79.5 86.9 USD | $79.5 86.9 USD | $30.59B 33.44B USD | 29.01 | $2.74 3 USD | |
| BeOne Medicines Ltd. 49BA.F | $222 242.68 USD |
-0.89
|
$25.63B 28.02B USD | $25 27.33 USD | $222 242.68 USD | $222 242.68 USD | $25.63B 28.02B USD | 0 | -$3.2 -3.4 USD | |
| BeOne Medicines Ltd. 49B.F | $16.51 18.04 USD |
-1.96
|
$25.36B 27.72B USD | $509 556.41 USD | $16.51 18.04 USD | $16.51 18.04 USD | $25.36B 27.72B USD | 0 | -$0.25 -0.2 USD | |
| BioNTech SE 22UA.F | $96.8 105.82 USD |
-2.07
|
$23.27B 25.44B USD | $2.49K 2.72K USD | $96 104.94 USD | $99.9 109.2 USD | $23.27B 25.44B USD | 0 | -$3.19 -3.4 USD | |
| Royalty Pharma plc RPD.F | $29.02 31.72 USD |
+0.1
|
$16.53B 18.07B USD | $15 16.4 USD | $29.02 31.72 USD | $29.02 31.72 USD | $16.53B 18.07B USD | 13.49 | $2.15 2.35 USD | |
| Innovent Biologics, Inc. 6IB.F | $7.9 8.64 USD |
-7.06
|
$12.94B 14.15B USD | $5.07K 5.54K USD | $7.75 8.47 USD | $8.35 9.13 USD | $12.94B 14.15B USD | 0 | -$0.01 -0.01 USD | |
| United Therapeutics Corporation UTH.F | $281.6 307.83 USD |
-0.53
|
$12.77B 13.96B USD | $15 16.4 USD | $281.6 307.83 USD | $281.6 307.83 USD | $12.77B 13.96B USD | 12.77 | $22.05 24.1 USD | |
| Insmed Incorporated IM8N.F | $67 73.24 USD |
+4.69
|
$12.2B 13.34B USD | $130 142.11 USD | $64.5 70.51 USD | $67 73.24 USD | $12.2B 13.34B USD | 0 | -$5.19 -5.6 USD | |
| Incyte Corporation ICY.F | $58.84 64.32 USD |
+0.1
|
$11.48B 12.55B USD | $17 18.58 USD | $58.84 64.32 USD | $58.84 64.32 USD | $11.48B 12.55B USD | 326.88 | $0.18 0.2 USD | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $2.76 3.02 USD |
-3.12
|
$11.23B 12.28B USD | $840 918.23 USD | $2.73 2.98 USD | $2.76 3.02 USD | $11.23B 12.28B USD | 27.60 | $0.1 0.11 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $5.4 5.9 USD |
-3.57
|
$10.99B 12.01B USD | $208 227.37 USD | $5.4 5.9 USD | $5.4 5.9 USD | $10.99B 12.01B USD | 28.42 | $0.19 0.21 USD | |
| Exelixis, Inc. EX9.F | $36.62 40.03 USD |
-1.48
|
$10.11B 11.06B USD | $230 251.42 USD | $36.62 40.03 USD | $36.62 40.03 USD | $10.11B 11.06B USD | 19.07 | $1.92 2.1 USD | |
| Verona Pharma plc I9SA.F | $71.8 78.49 USD |
-5.53
|
$9.97B 10.9B USD | $260 284.22 USD | $71.8 78.49 USD | $76.4 83.52 USD | $9.97B 10.9B USD | 0 | -$1.75 -1.9 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $48.92 53.48 USD |
-1.61
|
$9.38B 10.26B USD | $50 54.66 USD | $48.91 53.47 USD | $48.92 53.48 USD | $9.38B 10.26B USD | 20.72 | $2.36 2.58 USD | |
| Ascendis Pharma A/S A71.F | $151 165.06 USD |
-1.31
|
$9.13B 9.99B USD | $60 65.59 USD | $151 165.06 USD | $151 165.06 USD | $9.13B 9.99B USD | 0 | -$5.81 -6.3 USD | |
| Moderna, Inc. 0QF.F | $22.8 24.92 USD |
-7.68
|
$8.82B 9.64B USD | $1.58K 1.72K USD | $22.8 24.92 USD | $24.23 26.49 USD | $8.82B 9.64B USD | 0 | -$7.67 -8.3 USD | |
| Akeso, Inc. 4RY.F | $9.05 9.89 USD |
+1.12
|
$8.25B 9.01B USD | $172 188.02 USD | $9.05 9.89 USD | $9.1 9.95 USD | $8.25B 9.01B USD | 0 | -$0.07 -0.07 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| Blueprint Medicines Corporation 2L9.F | $111.5 121.88 USD |
-1.28
|
$7.24B 7.92B USD | $120 131.18 USD | $111.5 121.88 USD | $111.5 121.88 USD | $7.24B 7.92B USD | 0 | -$2.2 -2.4 USD | |
| Roivant Sciences Ltd. 87S.F | $9.6 10.49 USD |
+0.04
|
$6.66B 7.28B USD | $600 655.88 USD | $9.6 10.49 USD | $9.71 10.61 USD | $6.66B 7.28B USD | 0 | -$0.66 -0.7 USD | |
| Bio-Techne Corporation TE1.F | $41.8 45.69 USD |
-3.69
|
$6.61B 7.23B USD | $50 54.66 USD | $41.8 45.69 USD | $43 47 USD | $6.61B 7.23B USD | 57.26 | $0.73 0.8 USD | |
| Revolution Medicines, Inc. 42Z.F | $35 38.26 USD |
-0.57
|
$6.57B 7.18B USD | $86 94.01 USD | $35 38.26 USD | $35 38.26 USD | $6.57B 7.18B USD | 0 | -$3.52 -3.8 USD | |
| Corcept Therapeutics Incorporated HTD.F | $60.28 65.89 USD |
-1.34
|
$6.43B 7.03B USD | $115 125.71 USD | $60.28 65.89 USD | $60.76 66.42 USD | $6.43B 7.03B USD | 59.68 | $1.01 1.1 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $32.97 36.04 USD |
+0.83
|
$6.39B 6.99B USD | $100 109.31 USD | $32.97 36.04 USD | $32.97 36.04 USD | $6.39B 6.99B USD | 0 | -$3.13 -3.4 USD | |
| Sirius XM Holdings Inc. R 3HY.F | $18.75 20.5 USD |
-3.1
|
$6.34B 6.93B USD | $50 54.66 USD | $18.75 20.5 USD | $18.75 20.5 USD | $6.34B 6.93B USD | 0 | -$4.43 -4.8 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $94.86 103.69 USD |
-1.29
|
$5.85B 6.39B USD | $20 21.86 USD | $94.54 103.34 USD | $95.98 104.92 USD | $5.85B 6.39B USD | 14.66 | $6.47 7.07 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $46.96 51.33 USD |
+0.32
|
$5.79B 6.33B USD | $9 9.84 USD | $46.94 51.31 USD | $46.96 51.33 USD | $5.79B 6.33B USD | 14.27 | $3.29 3.6 USD | |
| Financière de Tubize SA FTD.F | $126.4 138.17 USD |
+0.64
|
$5.63B 6.15B USD | $70 76.52 USD | $126.4 138.17 USD | $126.4 138.17 USD | $5.63B 6.15B USD | 62.57 | $2.02 2.21 USD | |
| ALK-Abelló A/S 4AJ0.F | $24.62 26.91 USD |
+0.08
|
$5.43B 5.94B USD | $2 2.19 USD | $24.28 26.54 USD | $24.66 26.96 USD | $5.43B 5.94B USD | 43.96 | $0.56 0.61 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $238.8 261.04 USD |
-2.25
|
$5.33B 5.82B USD | $50 54.66 USD | $237.7 259.84 USD | $242.3 264.87 USD | $5.33B 5.82B USD | 0 | -$15.67 -17.1 USD | |
| 3SBio Inc. 83B.F | $2.14 2.34 USD |
-0.93
|
$5.13B 5.61B USD | $150 163.97 USD | $2.1 2.3 USD | $2.14 2.34 USD | $5.13B 5.61B USD | 21.40 | $0.1 0.11 USD | |
| TG Therapeutics, Inc. NKB2.F | $32.05 35.03 USD |
-4.07
|
$5.09B 5.56B USD | $45 49.19 USD | $32.05 35.03 USD | $32.05 35.03 USD | $5.09B 5.56B USD | 145.68 | $0.22 0.24 USD | |
| Legend Biotech Corporation 9LB.F | $27.2 29.73 USD |
+2.26
|
$5.02B 5.49B USD | $130 142.11 USD | $26.8 29.3 USD | $27.4 29.95 USD | $5.02B 5.49B USD | 0 | -$1.04 -1.1 USD | |
| Ionis Pharmaceuticals, Inc. ISI.F | $30.51 33.35 USD |
+0.49
|
$4.93B 5.39B USD | $755 825.32 USD | $30.51 33.35 USD | $30.51 33.35 USD | $4.93B 5.39B USD | 0 | -$2.63 -2.8 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Axsome Therapeutics, Inc. 19X.F | $93.56 102.27 USD |
-2.2
|
$4.77B 5.21B USD | $17 18.58 USD | $93.56 102.27 USD | $93.56 102.27 USD | $4.77B 5.21B USD | 0 | -$5.05 -5.5 USD | |
| Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.1B 4.48B USD | 0 | $0 0 USD | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $7.75 8.47 USD |
-5.49
|
$3.8B 4.15B USD | $170 185.83 USD | $7.75 8.47 USD | $7.75 8.47 USD | $3.8B 4.15B USD | 22.79 | $0.34 0.37 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Akero Therapeutics, Inc. 0K4.F | $46.18 50.48 USD |
+1.94
|
$3.78B 4.14B USD | $260 284.22 USD | $46.23 50.54 USD | $46.23 50.54 USD | $3.78B 4.14B USD | 0 | -$3.29 -3.5 USD | |
| Vaxcyte, Inc. 5VA.F | $28.2 30.83 USD |
-2.76
|
$3.73B 4.08B USD | $160 174.9 USD | $28.2 30.83 USD | $28.2 30.83 USD | $3.73B 4.08B USD | 0 | -$3.51 -3.8 USD | |
| Merus N.V. 2GH.F | $48.8 53.34 USD |
-2.01
|
$3.67B 4.02B USD | $200 218.63 USD | $48.8 53.34 USD | $49.2 53.78 USD | $3.67B 4.02B USD | 0 | -$3.66 -4.0008 USD | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $56 61.22 USD |
-2.61
|
$3.56B 3.89B USD | $20 21.86 USD | $56 61.22 USD | $56 61.22 USD | $3.56B 3.89B USD | 0 | -$2.46 -2.6 USD | |
| Zai Lab Limited 1ZL.F | $31.2 34.11 USD |
+5.41
|
$3.51B 3.83B USD | $230 251.42 USD | $31.2 34.11 USD | $31.2 34.11 USD | $3.51B 3.83B USD | 0 | -$2.2 -2.4 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| Camurus AB (publ) 7CA.F | $58.2 63.62 USD |
-5.06
|
$3.41B 3.73B USD | $1.22K 1.34K USD | $58.2 63.62 USD | $58.2 63.62 USD | $3.41B 3.73B USD | 69.28 | $0.84 0.92 USD | |
| Sarepta Therapeutics, Inc. AB3A.F | $34.34 37.54 USD |
+1.15
|
$3.37B 3.69B USD | $50 54.66 USD | $34.34 37.54 USD | $34.34 37.54 USD | $3.37B 3.69B USD | 0 | -$2.31 -2.5 USD | |
| Krystal Biotech, Inc. 4KB.F | $114.65 125.33 USD |
+0.44
|
$3.37B 3.68B USD | $190 207.7 USD | $114.65 125.33 USD | $114.65 125.33 USD | $3.37B 3.68B USD | 31.32 | $3.66 4 USD | |
| Cytokinetics, Incorporated KK3A.F | $27.6 30.17 USD |
-1.43
|
$3.35B 3.66B USD | $150 163.97 USD | $27.6 30.17 USD | $28.2 30.83 USD | $3.35B 3.66B USD | 0 | -$4.65 -5.08 USD | |
| Genscript Biotech Corporation G51.F | $1.48 1.62 USD |
-1.66
|
$3.22B 3.52B USD | $2.77K 3.03K USD | $1.45 1.58 USD | $1.48 1.62 USD | $3.22B 3.52B USD | 0 | -$0.07 -0.07 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $18.93 20.69 USD |
-3
|
$3.17B 3.46B USD | $100 109.31 USD | $18.93 20.69 USD | $18.93 20.69 USD | $3.17B 3.46B USD | 15.77 | $1.2 1.31 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $31.8 34.76 USD |
0
|
$3.05B 3.34B USD | $54 59.03 USD | $31.8 34.76 USD | $31.8 34.76 USD | $3.05B 3.34B USD | 0 | -$5.1 -5.5 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $55.35 60.51 USD |
+2.41
|
$2.91B 3.18B USD | $19 20.77 USD | $55.35 60.51 USD | $55.35 60.51 USD | $2.91B 3.18B USD | 20.27 | $2.73 2.98 USD | |
| Viking Therapeutics, Inc. 1VT.F | $23.98 26.21 USD |
+3.23
|
$2.75B 3.01B USD | $296 323.57 USD | $23.02 25.16 USD | $23.98 26.21 USD | $2.75B 3.01B USD | 0 | -$1.02 -1.1 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $22.16 24.22 USD |
+2.69
|
$2.71B 2.96B USD | $500 546.57 USD | $22.16 24.22 USD | $22.16 24.22 USD | $2.71B 2.96B USD | 16.17 | $1.37 1.5 USD | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $28 30.61 USD |
-0.71
|
$2.63B 2.87B USD | $60 65.59 USD | $28 30.61 USD | $28 30.61 USD | $2.63B 2.87B USD | 0 | -$3.33 -3.6 USD | |
| MorphoSys AG MOR2.F | $16.8 18.36 USD |
0
|
$2.61B 2.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61B 2.85B USD | 0 | $0 0 USD | |
| Morphic Holding, Inc. 31Y.F | $50 54.66 USD |
0
|
$2.6B 2.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6B 2.84B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.F | $67.8 74.11 USD |
0
|
$2.55B 2.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.55B 2.79B USD | 0 | $0 0 USD | |
| Scholar Rock Holding Corporation 2QK.F | $26.6 29.08 USD |
-1.48
|
$2.53B 2.77B USD | $20 21.86 USD | $26.6 29.08 USD | $26.6 29.08 USD | $2.53B 2.77B USD | 0 | -$2.24 -2.4 USD | |
| ImmunityBio, Inc. 26CA.F | $2.52 2.76 USD |
-0.9
|
$2.25B 2.46B USD | $4K 4.37K USD | $2.46 2.69 USD | $2.59 2.83 USD | $2.25B 2.46B USD | 0 | -$0.5 -0.5 USD | |
| Ascentage Pharma Group International 36X.F | $6.05 6.61 USD |
-0.82
|
$2.14B 2.34B USD | $200 218.63 USD | $6.05 6.61 USD | $6.05 6.61 USD | $2.14B 2.34B USD | 0 | -$0.16 -0.1 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $26.6 29.08 USD |
-0.75
|
$2.06B 2.25B USD | $40 43.73 USD | $26.6 29.08 USD | $26.6 29.08 USD | $2.06B 2.25B USD | 0 | -$2.82 -3.08 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $14.56 15.91 USD |
+0.41
|
$2.01B 2.2B USD | $80 87.45 USD | $14.56 15.91 USD | $14.56 15.91 USD | $2.01B 2.2B USD | 0 | -$1.09 -1.1 USD | |
| Vericel Corporation ATQP.F | $37.6 41.1 USD |
+3.87
|
$1.98B 2.17B USD | $130 142.11 USD | $37.6 41.1 USD | $37.6 41.1 USD | $1.98B 2.17B USD | 751.99 | $0.05 0.05 USD | |
| BioCryst Pharmaceuticals, Inc. BO1.F | $9.47 10.35 USD |
-4.19
|
$1.98B 2.17B USD | $190 207.7 USD | $9.47 10.35 USD | $9.58 10.47 USD | $1.98B 2.17B USD | 0 | -$0.23 -0.2 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $15.55 17 USD |
-8.45
|
$1.95B 2.14B USD | $240 262.35 USD | $15.55 17 USD | $15.55 17 USD | $1.95B 2.14B USD | 0 | -$1.58 -1.7 USD | |
| Veracyte, Inc. 12V.F | $24 26.24 USD |
+3.45
|
$1.94B 2.12B USD | $50 54.66 USD | $23.6 25.8 USD | $24 26.24 USD | $1.94B 2.12B USD | 64.86 | $0.37 0.4 USD | |
| Mirum Pharmaceuticals, Inc. 08D.F | $37.4 40.88 USD |
-2.09
|
$1.9B 2.08B USD | $26 28.42 USD | $37.4 40.88 USD | $37.8 41.32 USD | $1.9B 2.08B USD | 0 | -$1.41 -1.5 USD | |
| Denali Therapeutics Inc. 4DN.F | $12.55 13.72 USD |
+3.08
|
$1.9B 2.07B USD | $200 218.63 USD | $12.55 13.72 USD | $12.55 13.72 USD | $1.9B 2.07B USD | 0 | -$2.35 -2.5 USD | |
| Bavarian Nordic A/S BV3.F | $23.8 26.02 USD |
-0.21
|
$1.88B 2.05B USD | $8 8.75 USD | $23.8 26.02 USD | $24.47 26.75 USD | $1.88B 2.05B USD | 10.57 | $2.25 2.46 USD | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $90.5 98.93 USD |
+1.12
|
$1.76B 1.92B USD | $20 21.86 USD | $90.5 98.93 USD | $90.5 98.93 USD | $1.76B 1.92B USD | 0 | -$6.38 -6.9 USD | |
| Agios Pharmaceuticals, Inc. 8AP.F | $29.4 32.14 USD |
+1.38
|
$1.76B 1.92B USD | $54 59.03 USD | $29.4 32.14 USD | $29.4 32.14 USD | $1.76B 1.92B USD | 2.89 | $10.14 11.08 USD | |
| Everest Medicines Limited 6HN.F | $5.1 5.57 USD |
-0.97
|
$1.72B 1.88B USD | $212 231.74 USD | $5.1 5.57 USD | $5.1 5.57 USD | $1.72B 1.88B USD | 0 | -$0.4 -0.4 USD | |
| Galapagos NV GXEA.F | $24.8 27.11 USD |
-0.8
|
$1.66B 1.82B USD | $4 4.37 USD | $24.8 27.11 USD | $24.8 27.11 USD | $1.66B 1.82B USD | 0 | -$2.73 -2.9 USD | |
| BioArctic AB (publ) B9A.F | $18.18 19.87 USD |
+2.36
|
$1.66B 1.81B USD | $500 546.57 USD | $18.07 19.75 USD | $18.18 19.87 USD | $1.66B 1.81B USD | 19.54 | $0.93 1.02 USD | |
|
Không có cổ phiếu ưa thích
Bạn chưa có cổ phiếu ưa thích nào, hãy thêm nó vào mục ưa thích để thấy nó tại đây |
||||||||||